Three dimensional printing patient specific cutting guides for Pes cavus midfoot osteotomy—a retrospective cohort comparative study
International Orthopaedics · 2025-08 · 49 (8) · 1895-1904
DOI: 10.1007/s00264-025-06572-7 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Orthopaedics, online erschienen am 14.06.2025. Verfasst von Zhiyuan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Osteotomy, Talipes Cavus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Sichuan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: This comparative cohort study evaluates the clinical efficacy of 3D-printed patient-specific cutting guides (PSCGs) versus conventional manual techniques in correcting rigid midfoot pes cavus deformities. METHODS: A retrospective analysis of 40 patients (80 feet) undergoing Cole osteotomy between 2021 and 2023 was conducted. Patients were stratified into two matched cohorts: Group A (manual osteotomy, n = 20) and Group B (PSCG-assisted, n = 20). Radiographic parameters (Meary's angle, TMI, TCA, Djian-Annonier angle, Pitch angle) and functional outcomes (VAS, AOFAS, SF-36) were analyzed preoperatively and at mean 17-month follow-up. Surgical metrics including operative time, fluoroscopy frequency, and complication rates were systematically compared. RESULTS: Radiographic analysis demonstrated superior angular correction in the PSCG-assisted cohort versus conventional osteotomy, with significantly improved bilateral Meary's angle (Right: 1.94°±0.62 vs. 6.04°±2.20, P < 0.05; Left: 1.62°±0.54 vs. 6.39°±2.04, P < 0.05) and TMI angle (Right: 4.32°±3.14 vs. 8.51°±8.12, P < 0.05; Left: 4.74°±2.44 vs. 8.53°±5.93, P < 0.05). The PSCG technique achieved equivalent correction in TCA, Djian-Annonier, and Pitch angles while demonstrating enhanced consistency (38-66% reduction in standard deviations). Functionally, PSCG-assisted procedures yielded superior AOFAS scores (97.71 ± 0.77 vs. 92.07 ± 2.25, Δ = 5.64 [95%CI 4.54-6.74], P < 0.05) and SF-36 outcomes, particularly in general health (Δ = 16.96, P < 0.05) and mental well-being (Δ = 7.92, P = 0.001). Operative metrics favored PSCG with 36% shorter procedure time (82.9 ± 13.9 vs. 129.0 ± 39.6 min, P < 0.05) and 77% reduced intraoperative fluoroscopy (4.65 ± 1.06 vs. 20.07 ± 2.92 exposures, P < 0.05). No surgical site infections occurred in the PSCG group versus one superficial SSI in controls CONCLUSION: 3D-printed PSCGs provide anatomically precise, efficient correction of complex midfoot deformities while minimizing intraoperative radiation exposure, establishing this technology as a safe and reproducible alternative to conventional techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West China Hospital of Sichuan University, Chengdu, China.
- West China Hospital of Sichuan University, Chengdu, China. zhanghui1437@wchscu.cn.
Förderung
- Sichuan Provincial Natural Science Foundation of China
Zitieren
APA
Zhang, Z., Qin, B., Zhang, H., Yin, S., & Li, J. (2025). Three dimensional printing patient specific cutting guides for Pes cavus midfoot osteotomy—a retrospective cohort comparative study. International Orthopaedics, 49(8), 1895-1904. https://doi.org/10.1007/s00264-025-06572-7
Vancouver
Zhang Z, Qin B, Zhang H, Yin S, Li J. Three dimensional printing patient specific cutting guides for Pes cavus midfoot osteotomy—a retrospective cohort comparative study. International Orthopaedics. 2025;49(8):1895-1904. doi:10.1007/s00264-025-06572-7
BibTeX
@article{Zhang2025,
author = {Zhang, Zhiyuan and Qin, Boquan and Zhang, Hui and Yin, Shijiu and Li, Jia},
title = {Three dimensional printing patient specific cutting guides for Pes cavus midfoot osteotomy—a retrospective cohort comparative study},
journal = {International Orthopaedics},
year = {2025},
volume = {49},
number = {8},
pages = {1895--1904},
doi = {10.1007/s00264-025-06572-7}
}
EUVIMED